HUANG JAMES enters CASI PHARMACEUTICALS, INC. with 4.53M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 3/18/2026ACC: 0001193125-26-114091
4.53M
Baseline shares
0.00
Direct ownership
0 positions
121.57K
Derivative underlying
3 instruments
1
Security positions
4.53M indirect
Non-Derivative Holdings1
Ordinary Shares
IndirectShares owned4.53M
Total
4.53M indirect4.53M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 4.53M | Indirect |
| Total | 4.53M | 4.53M indirect |
Derivative Holdings3
Stock Option
DirectUnderlying security
Ordinary Shares
Underlying shares
10K
Shares owned
N/A
Exercise price
1.69
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Ordinary Shares
Underlying shares
10K
Shares owned
N/A
Exercise price
2.69
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Ordinary Shares
Underlying shares
101.57K
Shares owned
N/A
Exercise price
1.93
Expiration
—
Exercise window
—
Total
Underlying
121.57K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Ordinary Shares | 1.69 | — | — | 10K | N/A |
| Stock Option Direct | Ordinary Shares | 2.69 | — | — | 10K | N/A |
| Stock Option Direct | Ordinary Shares | 1.93 | — | — | 101.57K | N/A |
| Total | 121.57K | 0.00 | ||||